Study design
AFTER CATARACT, SECONDARY, INTRAOCULAR PRESSURE
This open-label, prospective, randomized, investigator-masked, real-world data, comparative clinical study was conducted from November 2020 to December 2021 at the SPEKTRUM Ophthalmology Clinical Centre. The study was conducted in accordance with the Good Clinical Practices and the tenets of the Declaration of Helsinki and approved by the Bioethics Committee of Wroclaw Medical University (KB 272/2017). The study was registered in the clinical trials by the number NCT05753787 (03/03/2023). All patients gave written informed consent to the study and to the surgery.The main outcome measures were fluorescein break-up time (FBUT), ocular surface staining, OSDI and subjective symptoms of DED evaluated before and 2 weeks after cataract surgery. The secondary outcome measures were anterior chamber (AC) cells grade and intraocular pressure assessed 2 weeks after surgery.